Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technologies to basic science cancer researchers – to create an environment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imaging adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Dr. Gambhir and Dr. Wu Recognized as Highly Cited Researchers of 2018

December 3, 2018

Noninvasive Ultrasonic Drug Uncaging Maps Whole-Brain Functional Networks

November 7, 2018

The New York Times Highlights Project Baseline Study

October 18, 2018

Dr. Katherine Ferrara Received Inaugural Leadership Award from WMIS WIMIN Group

September 20, 2018

Dr. Gambhir Appointed to Membership on the NIBIB Advisory Council

September 16, 2018

Aimen Zlitni, PhD, Received FUJIFILM VisualSonics Travel Award

September 14, 2018

MIPS Research Featured on the Cover of Clinical Cancer Research

September 7, 2018